Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
... NEW YORK Sept. 6 -- H.E.A.R.T 911 is ano...H.E.A.R.T 911 will respond nation-wide to situations that arise during...Bill Keegan was the Night Operations/Safety Commander for the FDNY at...Their W.T.C. Rescue/Recovery experience has given the H.E.A.R.T 911bo...
Date:9/6/2007
NEW YORK, Sept. 6 /PRNewswire-USNewswire/ -- H.E.A.R.T 911 is a
non-profit, non-sectarian volunteer response team comprised of veteran
police officers, fire fighters and construction trade union workers, all of
whom worked on rescue and recovery after the September 11th attacks and
surviving family members of those who died on 9/11.
H.E.A.R.T 911 will respond nation-wide to situations that arise during
natural or man-made disasters. The team's expertise is in developing
policy, procedures and programs for hazardous materials, confined space
rescue, mass fatality management, corporate asset recovery and terrorist
intelligence assessment.
Bill Keegan was the Night Operations/Safety Commander for the FDNY at
the World Trade Center site from September 11, 2001 until June 3, 2002.
During that time, Owen McCaffery and John Moran held the same positions as
Mr. Keegan at the site for the NYPD. Tom Thees financed a "thank you"
concert for 2,500 World Trade Center Recovery workers at the Beacon Theater
in July, 2002. Mr. Thees donated and raised money for many families who
lost loved ones in the attacks.
Their W.T.C. Rescue/Recovery experience has given the H.E.A.R.T 911
board a unique overview of the coordinated and sustained effort needed to
respond to a crisis. "The experience of 9/11 left us with an overwhelming
need to use what we've learned to aid in other disaster relief work", said
Keegan.
The current team is made up of about 100 firefighters, police officers
and construction workers who volunteered or worked on rescue and recovery
on September 11th. In the event of another man-made or natural disaster,
the team is ready and willing to help. H.E.A.R.T. 911 is currently in talks
with officials in New Orleans about the possibility of assisting with
rebuilding efforts in the local gulf community.
Family members who lost loved ones in the attacks have offered their
services and will work with residents who need emotional support and he
'/>"/>
SOURCE H.E.A.R.T 911 Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
NHS 24 Fails To Save a Retired Nurse2.
Ex-CIA Official Accuses Retired ISI Chief of Supporting Taliban3.
Williams Syndrome, the Brain, and Music4.
Structural Abnormalities in Brains of William Syndrome Patients5.
Indian Students Thrilled to Talk to Sunita Williams6.
Former smokers can be protected with vitamin A derivative7.
Reliable Help For Smokers From Nicotine Patches and Former Smokers8.
Former IMO President Shows Interest In Winning General Election9.
Former FDA Commissioner Accused in Criminal Case10.
Justice To Former Male Nurse In sex Discrimination Case11.
Residents Of Former Industrial Towns In UK Most likely To Become Obese
(Date:11/25/2009)...liticalEndorsements,Business,andPressJoinEfforttoE...wswire/--Onceagain,theNationalBipolarFoundationand...ngtheir"Safe,tilStable"program,whichisnowbeingwide...disorder.Today,theNationalBipolarFoundationreceive...tyMailfromtheLt.GovernorofLouisianaMitchLandrieu.T...
(Date:11/25/2009)... discovery that grew out of a collaboration betwee...offer hope to the nearly 10 million Americans who ...lso known as hardening of the arteries, peripheral... problem in which narrowed arteries reduce blood f...d flag for vascular disease, heart attack and stro...
(Date:11/25/2009)...dy used to fight rheumatoid arthritis, could help ..., WEDNESDAY, Nov. 25 (HealthDay News) -- A drug c...heumatoid arthritis now also shows some promise in...etes. , The drug, rituximab (Rituxan), helped p...even though the disease had destroyed some of thei...
(Date:11/25/2009)...plagued by neurological symptoms, study finds , ...Neurological side effects are among the potential ...r cancer who were treated with cisplatin-based che...ncluded 1,409 Norwegian men treated for unilateral...part in a follow-up survey conducted from 1998 to ...
(Date:11/25/2009)...N,Va.,Nov.25/PRNewswire-USNewswire/--TheAmericanAs...reFraudActof2009,"S.2128,whichisdesignedtosubstant...udinMedicare.ThebillwasintroducedbySen.GeorgeLeMie...visionstheAmericanAssociationforHomecareoutlinedin...nproposedtoCongressinFebruary.Thoseprovisionsinclu...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2...., May 15 Diagnostic Health Corporation,(DHC), an...es, has,announced the appointment of Robert E. Gon...day, May 19, 2008. In this role, Gontarek will ove...diology and,outpatient imaging business management...
...international volunteer service organization in Ch...ng-term needs, OAK BROOK, Ill., May 15 Today Lio... that it is mobilizing US$1.5,million to aid Lions...erful, massive,earthquake that struck Sichuan Prov...
... of them young children, were sickened after handl...5 (HealthDay News) -- An outbreak of Salmonella in... dry dog food, the first time such a link has been...ially young children, officials from the U.S. Cent...
...Sanofi-aventis announced that,the U.S. Court of Ap...ruary,8, 2007 decision by the U.S. District Court ...fi-aventis Lovenox(R) patent infringement suit,aga...considering all its legal options., While several...
...etic study in mice has identified hundreds of gene...ng the DNA of more than 500 lymphomas to find the ... over 10,000 mutations in total, which together im...e the other regions were novel, adding to our pict...
... May 15 Insulet Corporation,(Nasdaq: PODD ), a l...,OmniPod(R) Insulin Management System, today annou...nnual JMP Securities Research Conference.,Manageme...g the conference presentation, material informatio...
Other Medicine News:Health News:Diagnostic Health Corporation Names Robert E. Gontarek as COO 2Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 2Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 3Health News:Lions Mobilize $1.5 Million for China Earthquake Relief 4Health News:Salmonella Outbreak Linked to Dry Dog Food 2Health News:Salmonella Outbreak Linked to Dry Dog Food 3Health News:District Court Decision Affirmed in U.S. Lovenox(R) (enoxaparin sodium) Patent Infringement Case 2Health News:Connecting cancer genes 2(Date:11/24/2009)...SDA,Md.,Nov.24/PRNewswire-Asia/--ChindexInternatio...ndentAmericanproviderofWestern,healthcareproductsa...ncedthattheCompanywillattendthe21stAnnualPiperJaff...er1-2,2009,atthe,NewYorkPalaceHotel. , Manage...day,December1,2009,andholdone-on-onemeetingsthrou...
(Date:11/24/2009)...EGO,Nov.24/PRNewswire-FirstCall/--AnadysPharmaceut...resentatthe21stAnnualPiperJaffrayHealthcareConfere...ST).TheconferenceisbeingheldatTheNewYorkPalaceHote...icerofAnadys,willprovideanoverviewofAnadysanditscl...hecorporatepresentationwillbesimultaneouslywebcast...
(Date:11/24/2009)...ORD,Conn.,Nov.24/PRNewswire/--ZargisMedicalCorp.,a...ffromSiemensCorporateResearch(NYSE: SI ),todayanno...November24,2009episodeofCBS, TheEarlyShow duringas... magazine,reviewedfivewinningproductsfromthepublic...yShow isawidely-viewedtelevisionmorningnewstalksho...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Supelco 28R 29 and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water 13058 1Supelco 28R 29 and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water 13058 2Supelco 28R 29 and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water 13058 3Ready 3F AIM 21 Target Success 21 AIM Expands Global Reach Through Innovative Corporate Portal from Web to Enterprise 2 0 51877 1Ready 3F AIM 21 Target Success 21 AIM Expands Global Reach Through Innovative Corporate Portal from Web to Enterprise 2 0 51877 2Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 1Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 2Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 4...TLE, Dec. 10 Trubion Pharmaceuticals,Inc. (Nasdaq...als has,initiated a Phase I/II clinical trial of T...eutical (SMIP(TM)) drug candidate, for the treatme...zed, open label,uncontrolled, single-group assignm...ety and efficacy of TRU-015 in subjects with NHL. ...
...NTA, Dec. 10 Exelixis, Inc. (Nasdaq:,EXEL), today...al of XL019,in patients with myelofibrosis, a myel...gational small molecule that selectively inhibits ...embers activated in response to,cytokines and hema...activated in the majority of MPD patients and is d...
Other Medicine Technology:Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma 2Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma 3Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma 4Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 2Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 3Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2 4... the Aliquoting System RSD 800A with an Automatic ...n an efficient System and a complete solution for ...t front-end and back-end features: centrifuging, t...e quality control, decapping, barcode printing and...
...n individually configurable System for decapping, ... type identification via cap recognition is option...in a clearly organized workflow. The input and out...pacity. The System can simply be loaded with vario...
...different specimen in one run. Complex scanning an... samples are sorted, decapped and archived in a ve... given sorting priorities. Optionally a Tube Type ...Module can be integrated. Selectively decapping is...
...e molecular labs a more advanced alternative for r...logy, combined with post-PCR dissociation melt cur...lar labs more powerful tools for detecting nucleic...utations associated with disease, as well as enabl...
Medicine Products: